Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It ...
Introduction By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in ...
Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity ...
HealthDay on MSN
Antibiotic Resistance Rising Fast, WHO Warns
Dangerous infections that no longer respond to antibiotics are spreading quickly around the world, increasing by as much as 15% a year.
With this in mind, microbiologist professor Brenda Wilson of the University of Illinois Urbana-Champaign, has shared what you ...
A new report from the Centers for Disease Control and Prevention on the deadly drug-resistant bacteria NDM-CRE found a 70% rise in infections in the U.S. between 2019 and 2023. Also known as ...
News-Medical.Net on MSN
Global antibiotic resistance reaches alarming levels in 2023
One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to ...
Antibiotics start working immediately by rupturing the protective cell walls of harmful bacteria, but you may not feel relief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback